20.500.12556/ReVIS-11646 SPREMLJANJE BOLNIKOV Z DEMENCO OB FARMAKOLOŠKEM ZDRAVLJENJU MONITORING PATIENTS WITH DEMENTIA OF PHARMACOLOGICAL TREATMENT zhodišča: Demenca je ena najpogostejših nevrodegenerativnih bolezni, ki pomembno vpliva na kognitivne, vedenjske in telesne funkcije bolnikov ter predstavlja velik izziv za zdravstveno oskrbo. Glavni namen raziskave je bil preučiti spremljanje bolnikov z demenco ob farmakološkem zdravljenju, prepoznati izzive, povezane s tem procesom, in ovrednotiti možnosti za izboljšanje prakse. Metode: Izvedena je bila kvalitativna raziskava s pomočjo fokusnih skupin. V raziskavi je sodelovalo deset zdravstvenih delavcev – pet medicinskih sester in pet zdravnikov – zaposlenih na Nevrološki kliniki, Kliničnem oddelku za bolezni živčevja Alfreda Šerka, Univerzitetnega kliničnega centra Ljubljana. Podatki so bili zbrani z delno strukturiranim intervjujem v fokusnih skupinah, nato pa analizirani z uporabo tematske analize, kar je omogočilo identifikacijo ključnih tem in kod v izjavah udeležencev. Rezultati: Med glavnimi izzivi so udeleženci izpostavili pomanjkanje farmakološkega znanja, časovne in kadrovske omejitve ter potrebo po boljši dokumentaciji. Antidementivi, kot so rivastigmin, donepezil, galantemin in memantin, so bili prepoznani kot ključni za zgodnje faze demence, medtem ko so antipsihotiki učinkoviti za obvladovanje vedenjskih simptomov. Sistematična uporaba obrazca BSO-DOS? bi lahko izboljšala spremljanje vedenjskih sprememb in prilagoditev terapij. Razprava: Multidisciplinarno sodelovanje, dodatno izobraževanje in uvedba standardiziranih orodij, kot je obrazec BSO-DOS?, so ključni za izboljšanje oskrbe bolnikov. Priporočljivo je tudi večje vključevanje nefarmakoloških metod, ki dopolnjujejo farmakološko zdravljenje in zmanjšujejo neželene učinke. Introduction: Dementia is one of the most common neurodegenerative diseases, significantly affecting patients' cognitive, behavioral, and physical functions, and posing a major challenge to healthcare systems. The main aim of this research was to examine the monitoring of patients with dementia during pharmacological treatment, identify challenges associated with this process, and evaluate opportunities for improving practices. Methods: A qualitative study was conducted using focus group interviews. The study included ten healthcare professionals—five nurses and five physicians—employed at the Neurology Clinic, Alfred Šerko Department of Neurological Disorders, University Medical Centre Ljubljana. Data were collected through semi-structured interviews in focus groups and subsequently analyzed using thematic analysis, which enabled the identification of key themes and codes in the participants' statements. Results: Participants highlighted major challenges such as a lack of pharmacological knowledge, time constraints, staffing limitations, and the need for better documentation. Antidementia drugs, such as rivastigmine, donepezil, galantamine and memantine, were identified as crucial in the early stages of dementia, while antipsychotics were effective in managing behavioral symptoms. Systematic use of the BSO-DOS form could enhance the monitoring of behavioral changes and improve therapy adjustments. Discussion: Multidisciplinary collaboration, additional training, and the introduction of standardized tools, such as the BSO-DOS form, are essential for improving patient care. Greater integration of non-pharmacological methods, complementing pharmacological treatments and reducing side effects, is also recommended. demenca antidementivi farmakološko zdravljenje spremljanje bolnikov z demenco multidisciplinarni tim. dementia antidementia drugs pharmacological treatment monitoring patients with dementia multidisciplinary team. true false false Slovenski jezik Angleški jezik Diplomsko delo/naloga 2025-04-26 18:04:21 2025-04-26 18:04:21 2025-05-26 08:49:03 0000-00-00 00:00:00 2025 0 0 0000-00-00 NiDoloceno NiDoloceno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 21277 236239107 DIP_Erjavec_Lucija_2025.pdf DIP_Erjavec_Lucija_2025.pdf 1 A8087C9DF356C5F949F1A17E686AC0F9 9e77fdad3e2d0a6095d7269ba49201dc88546ce4025a7b3bdff52fd80a519851 1ddbf4a5-22b8-11f0-963a-001a4af901a5 https://revis.openscience.si/Dokument.php?lang=slv&id=13430 Univerza v Novem mestu - Fakulteta za zdravstvene vede 0 0 0